TIDMHELD
RNS Number : 2334U
Hellenic Dynamics PLC
27 March 2023
27 March 2023
Hellenic Dynamics plc
("Hellenic Dynamics" or the "Company")
Appointment of Katherine Fleming to Advisory Board
London, 27 March 2023: Hellenic Dynamics plc (LSE: HELD) a
medical cannabis cultivation company, is pleased to announce the
appointment of Katherine Fleming to its Advisory Board. Katherine
is currently the President and CEO of the J. Paul Getty Trust, the
international cultural and philanthropic institution, overseeing
its 1,500 employees and US$8.5 billion endowment fund.
Katherine previously held the position of Provost and Professor
of History of New York University, the largest private university
in the United States by enrolment, where she is also the Alexander
S. Onassis Chair of Hellenic Studies. As Provost, she oversaw the
University's global academic strategy and was responsible for
budgetary allocation. Past international appointments have included
serving as President of the Board of the University of Piraeus,
Greece and as associate member of the faculty of the École Normale
Supérieure in Paris, France.
Katherine holds a number of honours including being named to the
French Légion d'Honneur and being decorated by the Greek Government
as a commander in the Order of Beneficence. In 2016 Katherine was
recognized for her contributions to Greek culture by being granted
honorary Greek citizenship.
Katherine will assist Hellenic Dynamics both domestically in
Greece with her strong and well-established relationships, as well
as on the international stage as it aims to be the dominant
supplier of THC medical cannabis products in Europe.
Hellenic Dynamics is a medical cannabis cultivator specifically
focused on the cultivation and supply of tetrahydrocannabinol ("
THC") dominant strains of medical cannabis flowers destined for the
rapidly growing medical cannabis markets across Europe. In December
2022, Hellenic Dynamics became the first medical cannabis
cultivator to list on the London Stock Exchange's main market for
listed securities.
Davinder Rai, CEO of Hellenic Dynamics, commented:
"We are honoured to have Katherine join our Advisory Board and I
personally look forward to working with her. Katherine brings a
huge breadth of experience that will benefit Hellenic both
domestically in Greece and in wider Europe."
Katherine Fleming, commented:
"I'm delighted to join Hellenic Dynamics, which connects two
worlds about which I care deeply: patients for whom medical
cannabis can improve their quality of life and outcomes, and Greece
- a country with massive potential for being the leader in the
European medical cannabis cultivation space."
Enquires:
Hellenic Dynamics plc +44 (0)20 3818 7850
Davinder Rai davinder@hellenicdynamics.com
Cairn Financial Advisers LLP
Emily Staples / Jo Turner +44 (0)20 7213 0880
Peterhouse Capital
Lucy Williams / Charles Goodfellow +44 (0)20 7469 0930
J&H Communications
George Hudson +44 (0)7803 603130
About Hellenic Dynamics plc
Founded in 2019, Hellenic Dynamics is specifically focused on
the cultivation and supply of THC ("tetrahydrocannabinol") -
dominant strains of medical cannabis flowers, destined for the
growing medical cannabis markets across Europe. Hellenic Dynamics'
core strategy is to develop and operate its 40,000 square metre
active cultivation licence from its 195,506 square metre facility
located near Thessaloniki in Northern Greece. In full production,
Hellenic Dynamics is capable of producing over 54,000 kg of dried
flowers per annum.
Hellenic Dynamics will take advantage of its relatively low cost
base resulting from a comparatively low cost of power, having its
own running water supply and the labour rates for skilled and
semi-skilled labour in Northern Greece.
25 European countries now allow medical cannabis via
prescription and the European cannabis market is expected to reach
EUR43.3 billion per annum by 2027. Sales of Hellenic Dynamics'
dried THC-dominant cannabis flowers and extracts are initially
intended for export into Europe's largest market - Germany, in
addition to other European markets including domestically in
Greece.
As the first medical cannabis cultivator to obtain a listing on
the main market for listed securities of the London Stock Exchange,
Hellenic is significantly different to the number of CBD
(Cannabidiol) related companies that have appeared over the recent
years. Hellenic Dynamics cultivates THC-dominant medical cannabis
flowers. THC-dominant medical cannabis products are only available
via a medical prescription. Medicinal cannabis has been approved
for use both in the United Kingdom and Germany, plus 23 other
European countries, for conditions including but not limited to
chronic pain, intractable chemotherapy-related nausea, anxiety,
insomnia, Tourette's syndrome, substance use disorder, multiple
sclerosis, IBS, spinal cord treatment, lack of appetite due to
HIV/AIDS, cachexia, anorexia and glaucoma.
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed
to be, forward looking statements. Forward looking statements are
identi ed by their use of terms and phrases such as "believe",
"could", "should" "envisage", "estimate", "intend", "may", "plan",
"potentially", "expect", "will" or the negative of those,
variations or comparable expressions, including references to
assumptions. These forward-looking statements are not based on
historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of
operations, performance, future capital and other expenditures
(including the amount, nature and sources of funding thereof),
competitive advantages, business prospects and opportunities. Such
forward looking statements re ect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCKZGZFGVVGFZZ
(END) Dow Jones Newswires
March 27, 2023 02:00 ET (06:00 GMT)
Mountfield (LSE:MOGP)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Mountfield (LSE:MOGP)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
